the most interesting part in the upcoming investor webinar will be to hear why they don’t want to wait till the second quarter results which should be published in October
there must be something that warrants a separate webinar and it can’t wait for another 5 weeks till the next reporting cycle
my thoughts:
1) sale guidance upgrade - currently it assumes zero growth in the H2
2) further info on the soft tissue results
3) meeting with FDA on rejuvenation
the most interesting part in the upcoming investor webinar will...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.01 |
Change
0.070(2.38%) |
Mkt cap ! $210.5M | |||
| Open | High | Low | Value | Volume |
| $3.00 | $3.04 | $2.97 | $754.2K | 251.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 664 | $3.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.01 | 2812 | 1 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| AVH (ASX) Chart |